<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">90749</article-id><article-id pub-id-type="doi">10.7554/eLife.90749</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.90749.4</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Txnip deletions and missense alleles prolong the survival of cones in a retinitis pigmentosa mouse model</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-177334"><name><surname>Xue</surname><given-names>Yunlu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2088-9826</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-356042"><name><surname>Zhou</surname><given-names>Yimin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2493"><name><surname>Cepko</surname><given-names>Constance L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9945-6387</contrib-id><email>cepko@genetics.med.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Departments of Genetics and Ophthalmology, Blavatnik Institute, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Lingang Laboratory</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/030bhh786</institution-id><institution>School of Life Science and Technology, ShanghaiTech University</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Eade</surname><given-names>Kevin</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jgzvw27</institution-id><institution>The Lowy Medical Research Institute</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Smith</surname><given-names>Lois EH</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00dvg7y05</institution-id><institution>Boston Children's Hospital</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>10</day><month>05</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP90749</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-07-20"><day>20</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-08-05"><day>05</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.03.551766"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-09-15"><day>15</day><month>09</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90749.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-20"><day>20</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90749.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-05-01"><day>01</day><month>05</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90749.3"/></event></pub-history><permissions><copyright-statement>© 2023, Xue et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Xue et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-90749-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-90749-figures-v1.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.66240" id="ra1"/><abstract><p>Retinitis pigmentosa (RP) is an inherited retinal disease in which there is a loss of cone-mediated daylight vision. As there are &gt;100 disease genes, our goal is to preserve cone vision in a disease gene-agnostic manner. Previously we showed that overexpressing TXNIP, an α-arrestin protein, prolonged cone vision in RP mouse models, using an AAV to express it only in cones. Here, we expressed different alleles of <italic>Txnip</italic> in the retinal pigmented epithelium (RPE), a support layer for cones. Our goal was to learn more of TXNIP’s structure-function relationships for cone survival, as well as determine the optimal cell type expression pattern for cone survival. The C-terminal half of TXNIP was found to be sufficient to remove GLUT1 from the cell surface, and improved RP cone survival, when expressed in the RPE, but not in cones. Knock-down of HSP90AB1, a TXNIP-interactor which regulates metabolism, improved the survival of cones alone and was additive for cone survival when combined with TXNIP. From these and other results, it is likely that TXNIP interacts with several proteins in the RPE to indirectly support cone survival, with some of these interactions different from those that lead to cone survival when expressed only in cones.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>TXNIP</kwd><kwd>retina</kwd><kwd>HSP90AB1</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>K99EY030951</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Yunlu</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cepko</surname><given-names>Constance L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Lingang Laboratory</institution></institution-wrap></funding-source><award-id>Start up fund</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Yunlu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Multiple alleles of Txnip, which can interact with several different proteins, including Hsp90AB1, were tested for their ability to prolong the survival of cone photoreceptors in diseases leading to blindness.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Retinitis pigmentosa (RP) is an inherited retinal degenerative disease that affects one in ~4000 people worldwide (<xref ref-type="bibr" rid="bib6">Hartong et al., 2006</xref>). The disease first manifests as poor night vision, likely due to the fact that many RP disease genes are expressed in rod photoreceptors, which initiate night vision. Cone photoreceptors, which are required for daylight, color, and high acuity vision, also are affected, as are the retina-pigmented epithelial (RPE) cells (<xref ref-type="bibr" rid="bib1">Chrenek et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Napoli et al., 2021</xref>; <xref ref-type="bibr" rid="bib21">Napoli and Strettoi, 2023</xref>; <xref ref-type="bibr" rid="bib34">Wu et al., 2021</xref>), which support both rod and cone photoreceptors. However, cones and RPE cells typically do not express RP disease genes. Nonetheless, RP cones lose function and die after most of the rods in their immediate neighborhood die. While it is not entirely clear what causes cone death, there are data suggesting problems with metabolism, oxidative stress, lack of trophic factors, oversupply of chromophore, and inflammation (<xref ref-type="bibr" rid="bib15">Komeima et al., 2006</xref>; <xref ref-type="bibr" rid="bib18">Mohand-Said et al., 1998</xref>; <xref ref-type="bibr" rid="bib27">Punzo et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Xue et al., 2023</xref>; <xref ref-type="bibr" rid="bib40">Zhao et al., 2015</xref>). We have been pursuing gene therapy to address some of these problems. Our hope is to create therapies that are disease-gene agnostic by targeting common problems for cones across disease gene families. One of our strategies is aimed at cone metabolism. Several lines of evidence suggest that RP cones do not have enough glucose, their main fuel source (Reviewed in <xref ref-type="bibr" rid="bib37">Xue and Cepko, 2023</xref>). We found that overexpression of TXNIP, an α-arrestin protein with multiple functions, including glucose metabolism, prolonged the survival of cones and cone-mediated vision in three RP mouse strains (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). Regarding the mechanism of rescue, we found that it relied upon the utilization of lactate by cones. In addition, cones treated with Txnip showed improved mitochondrial morphology and function. As TXNIP is known to bind directly to thioredoxin, we tested a <italic>Txnip</italic> allele with a single amino acid (aa) change, C247S, which abolishes the interaction with thioredoxin (<xref ref-type="bibr" rid="bib24">Patwari et al., 2006</xref>). This allele provided better rescue than the wild-type (wt) <italic>Txnip</italic> allele, ruling out its interaction with thioredoxin as required for cone rescue. These findings inspired us to further modify Txnip in various ways to look for better rescue, as well as to explore potential mechanisms for Txnip’s action. To this end, we also tested a related α-arrestin protein, as well as an interacting partner, for rescue effects.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Arrdc4</italic> reduces <italic>rd1</italic> cone survival</title><p>As TXNIP is a member of the α-arrestin protein family, we explored whether another family member might prolong RP cone survival. There are six known α-arrestins in mammals (<xref ref-type="bibr" rid="bib26">Puca and Brou, 2014</xref>). Among them, arrestin domain-containing protein 4 (ARRDC4) is the closest to TXNIP in amino acid sequence, sharing ~60% similar amino acids with TXNIP (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). ARRDC4 is thought to have functions that are similar to those of TXNIP in regulating glucose metabolism in vitro (<xref ref-type="bibr" rid="bib25">Patwari et al., 2009</xref>). Like TXNIP and other α-arrestins, ARRDC4 is composed of three domains: a N-terminal arrestin (Arrestin N-) domain, a C-terminal arrestin (Arrestin C-) domain, and an intrinsically disordered region (IDR) at the C-terminus. Because an IDR lacks a stable 3D structure under physiological conditions, previous studies using crystallography did not reveal the full structure of the TXNIP protein (<xref ref-type="bibr" rid="bib9">Hwang et al., 2014</xref>). None of the other α-arrestins have been characterized structurally. To begin to examine potential similarities in structure among some of these family members, we utilized an artificial intelligence (AI) algorithm, AlphaFold-2, to visualize the predicted 3D full structure of ARRDC4 (<xref ref-type="bibr" rid="bib14">Jumper et al., 2021</xref>). Similar to TXNIP, ARRDC4 is predicted to have a ‘W’ shaped arrestin structure, which is composed of the Arrestin N- and C-domains, plus a long IDR which looks like a tail (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Effect of arrestin domain containing protein 4 (Arrdc4) on cone survival in retinitis pigmentosa mice.</title><p>(<bold>A</bold>) Amino acid sequences of mouse TXNIP and mouse ARRDC4. In the full-length alignment (421 amino acid), Identity: 172/421, 40.86%; Similarity: 246/421, 58.43%; Gaps: 28/421, 6.65%. Color code: identical, black; similar, blue; not similar, red. (<bold>B</bold>) Predicted 3D protein structures of mouse TXNIP and mouse ARRDC4 by artificial intelligence (AI) algorithm AlphaFold-2. Abbreviations: Arr N-, N-terminal arrestin domain; Arr C-, C-terminal arrestin domain. (<bold>C</bold>) Representative P50 <italic>rd1</italic> flat-mounted retinas after P0 subretinal infection with AAV8-RO1.7-Arrdc4 (1×10<sup>9</sup> vg/eye), plus AAV8-RedO-H2BGFP (2.5×10<sup>8</sup> vg/eye), or control eyes infected with AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye alone. (<bold>D</bold>) Quantification of H2BGFP-positive cones within the center of P50 <italic>rd1</italic> retinas transduced with Arrdc4, and control (same as in C). The number in the round brackets ‘()’ indicates the number of retinas within each group. Error bar: standard deviation. Statistics: two-tailed unpaired Student’s t-test. **** p&lt;or &lt;&lt; 0.0001. RedO: red opsin promoter; RO1.7: a 1.7 kb version of red opsin promoter. AAV: adeno-associated virus.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>This file contains the source data of <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90749-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig1-v1.tif"/></fig><p><italic>Arrdc4</italic> was tested for its ability to prolong cone survival in <italic>rd1</italic> mice using AAV-mediated gene delivery, as was done for <italic>Txnip</italic> previously (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). Expression of <italic>Arrdc4</italic> was driven by a cone-specific promoter, RO1.7, derived from human red opsin (<xref ref-type="bibr" rid="bib16">Krol et al., 2010</xref>; <xref ref-type="bibr" rid="bib31">Wang et al., 1992</xref>; <xref ref-type="bibr" rid="bib39">Ye et al., 2016</xref>). The vector was packaged into the AAV8 serotype capsid. AAV-Arrdc4 was injected sub-retinally into P0 <italic>rd1</italic> mouse eyes along with AAV-H2BGFP, which is used to trace the infection and to label the cone nuclei for counting. At P50, the treated retinas were harvested and flat-mounted for further quantification of cones within the central retina, the area that first degenerates. Unlike Txnip, the cone counts were much lower in Arrdc4 treated retina relative to the AAV-H2BGFP control (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>).</p></sec><sec id="s2-2"><title>Evaluation of cone survival using <italic>Txnip</italic> deletion alleles expressed in the RPE</title><p>We previously showed (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>) that overexpressing the <italic>Txnip</italic> wt allele in the RPE using an RPE-specific promoter, derived from the human <italic>BEST1</italic> gene (<xref ref-type="bibr" rid="bib3">Esumi et al., 2009</xref>), did not improve RP cone survival. The wt allele removes the glucose transporter from the plasma membrane, thus preventing the RPE from taking up glucose for its own metabolism, and preventing it from serving as a conduit for glucose to flow from the blood to the cones. However, a triple mutant, Txnip.C247S.LL351 and 352AA, improved cone survival when expressed only in the RPE (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). The C247S mutation eliminates the interaction with thioredoxin, and enhances the Txnip rescue when expressed in cones (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). The LL351 and 352AA mutations eliminate a clathrin-binding site, which is required for Txnip’s interaction with clathrin-coated pits for removal of GLUT1 from the cell surface (<xref ref-type="bibr" rid="bib33">Wu et al., 2013</xref>). We previously proposed a model in which Txnip.C247S.LL351 and 352AA promotes the use of lactate by the RPE (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>), as we found was the case when Txnip was expressed in cones. Although the RPE normally uses lactate in wt animals, in RP, it is hypothesized that it retains the glucose that it normally would deliver to cones (Reviewed in <xref ref-type="bibr" rid="bib8">Hurley, 2021</xref>). The retention of glucose by the RPE is thought to be due to a reduction in lactate supply, as rods normally provide lactate for the RPE, and with rod loss that source would be greatly diminished. If the RPE can utilize lactate in RP, perhaps using lactate supplied by the blood, and the LL351 and 352AA mutation impairs the ability of TXNIP to remove the glucose transporter from the plasma membrane, this allele of <italic>Txnip</italic> may then allow glucose to flow from the blood to the cones via the GLUT1 transporter. The expression of Txnip.C247S.LL351 and 352AA allele thus has the potential to address the proposed glucose shortage of RP cones. However, we noted two caveats. One is that the survival of cones was not as robust as when <italic>Txnip</italic> was expressed directly in cones. In addition, the <italic>rd1</italic> retina in the FVB strain used here, even without any treatment, shows holes in the cone layer, which appear as ‘craters.’ An RP rat model presents a similar pattern (<xref ref-type="bibr" rid="bib12">Ji et al., 2014</xref>; <xref ref-type="bibr" rid="bib11">Ji et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Zhu et al., 2013</xref>). When Txnip.C247S.LL351 and 352AA are expressed in the RPE, there are more craters in the photoreceptor layer. We note that these craters are common only in the <italic>rd1</italic> allele on the FVB background, i.e., not as common on other inbred mouse strains that also harbor the <italic>rd1</italic> allele, so the meaning of this observation is unclear.</p><p>Arrestins are well-known for their protein-protein interactions via different domains. Different regions of TXNIP are known to directly associate with different protein partners to affect several different functions. For example, the N-terminus is sufficient to interact with KPNA2 for TXNIP’s localization to the nucleus (<xref ref-type="bibr" rid="bib22">Nishinaka et al., 2004</xref>), while the C-terminus of TXNIP is critical for interactions with COPS5, to inhibit cancer cell proliferation (<xref ref-type="bibr" rid="bib10">Jeon et al., 2005</xref>). The C-terminus of TXNIP is also necessary for inhibition of glycolysis, at least in vitro, through an unclear mechanism (<xref ref-type="bibr" rid="bib25">Patwari et al., 2009</xref>). Based on these studies, we made several deletion alleles of <italic>Txnip</italic>, and expressed them in the RPE using the Best1 promoter. We assayed their ability to clear GLUT1 from the RPE surface (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), as well as promote cone survival (<xref ref-type="fig" rid="fig2">Figure 2B–G</xref>). To enable automated cone counting and trace the infection, we co-injected an AAV (AAV8-RedO-H2BGFP-WPRE-bGHpA) encoding an allele of GFP fused to histone 2B (H2BGFP), which localized to the nucleus. As the red opsin promoter was used to express this gene, H2BGFP was seen in cone nuclei, but not in the RPE, if AAV8-RedO-H2BGFP-WPRE-bGHpA was injected alone. However, when an AAV that expressed in the RPE, i.e., AAV8-Best1-Sv40intron-(Gene)-WPRE-bGHpA, was co-injected with AAV8-RedO-H2BGFP-WPRE-bGHpA, H2BGFP was expressed in the RPE, along with expression in cones (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We speculate that this is due to concatenation or recombination of the two genomes, such that the H2BGFP comes under the control of the RPE promoter. This may be due to the high copy number of AAV in the RPE, as it did not happen in the reverse combination, i.e., AAV with an RPE promoter driving GFP and a cone promoter driving another gene. It was previously observed that the AAV genome copy number was »10 fold lower in cones than in the RPE (<xref ref-type="bibr" rid="bib32">Wang et al., 2020</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Txnip</italic> deletions expressed only within retinal pigmented epithelium (RPE) cells: effects on GLUT1 removal and cone survival.</title><p>(<bold>A</bold>) Glucose transporter 1 (GLUT1) expression in P20 wild-type eyes infected with control (AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye), or a <italic>Txnip</italic> allele (2.5×10<sup>8</sup> vg/eye) plus RedO-H2BGFP (2.5×10<sup>8</sup> vg/eye), as indicated in each panel. <italic>Txnip</italic> deletions are detailed in <xref ref-type="fig" rid="fig4">Figure 4</xref>. GLUT1 intensity from basal RPE is quantified in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>. Magenta: GLUT1; green: RedO-H2BGFP for infection tracing; gray: DAPI. (<bold>B, D, F</bold>) Representative P50 <italic>rd1</italic> flat-mounted retinas after P0 infection with one of seven different <italic>Txnip</italic> alleles expressed only within the RPE, as indicated in the figure, or control eyes infected with AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye alone. (<bold>C, E, G</bold>) Quantification of H2BGFP-positive cones within the center of P50 <italic>rd1</italic> retinas transduced with indicated vectors, as shown in B, D, F. The number in the round brackets ‘()’ indicates the number of retinas within each group. Error bar: standard deviation. Statistics: ANOVA and Dunnett’s multiple comparison test for C and E; two-tailed unpaired Student’s t-test for G. C.Txnip.CS: C-terminal portion of Txnip.C247S; C.Txnip.CS.LLAA: C-terminal portion of Txnip.C247S.LL351 and 352AA; nt.Txnip.CS<sup>320</sup>: no tail Txnip (1-320aa). NS: not significant, p&gt;0.05, *p&lt;0.05, **p&lt;0.01, ****p&lt;or &lt;&lt; 0.0001. Best1: Best1 promoter.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>This file contains the source data of <xref ref-type="fig" rid="fig2">Figure 2C, E and G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90749-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>Txnip</italic> deletions expressed only within retinal pigmented epithelium (RPE) cells: quantification of the Glucose transporter 1 (GLUT1) level within the basal surface of the RPE.</title><p>GLUT1 expression in P20 wild-type (wt) eyes infected with control (AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye), or a <italic>Txnip</italic> allele (2.5×10<sup>8</sup> vg/eye) plus RedO-H2BGFP (2.5×10<sup>8</sup> vg/eye), as indicated in each panel. <italic>Txnip</italic> deletions are detailed in <xref ref-type="fig" rid="fig4">Figure 4</xref>. Wt Txnip (red group) and Txnip.C247S.LLAA (blue group) were published previously (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>), and are repeated here using the same conditions as in this study for comparison to the new alleles. Only regions that were infected, as indicated by the H2BGFP marker that was co-injected, were analyzed. GLUT1 intensity from regions of interest (ROIs) within the basal RPE was quantified. Red: GLUT1; green: RedO-H2BGFP for infection tracing; gray: DAPI. Arrows: RPE basal surface. Sample size: control, 26 ROIs from four eyes; Txnip.C247S, nine ROIs from three eyes; N.Txnip, 36 ROIs from six eyes; sC.Txnip, 10 ROIs from six eyes; C.Txnip.CS, 13 ROIs from three eyes, C.Txnip.CS.LLAA, seven ROIs from three eyes; nt.Txnip.CS<sup>320</sup>, 14 ROIs from four eyes; wt Txnip, 11 ROIs from four eyes; Txnip.CS.LLAA, 21 ROIs from four eyes. Error bar: standard deviation. Statistics: Mann-Whitney U Test compared to control with Bonferroni correction. NS: not significant, ***p&lt;0.001, ****p&lt;or &lt;&lt; 0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Predicted protein-protein interactions of TXNIP and Glucose transporter 1 (GLUT1) by an algorithm, ColabFold, based on AlphaFold-2.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig2-figsupp2-v1.tif"/></fig></fig-group><p>To assay GLUT1, we focused on the basal surface of the RPE, as it is easier to score than the apical surface, where its processes are intertwined with those of the retina, where GLUT1 is also expressed. The 149-397aa portion of Txnip.C247S (C.Txnip.C247S) had the highest activity for GLUT1 removal from the RPE basal surface in vivo, while the 1-228aa portion (N.Txnip) failed to remove GLUT1 (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). As predicted by ColabFold, an AI algorithm based on AlphaFold-2 (<xref ref-type="bibr" rid="bib17">Mirdita et al., 2022</xref>), the Arrestin C-domain, which is part of C.Txnip.C247S, but is not present in the N-domain of TXNIP, interacts with the intracellular C-terminal IDR of GLUT1 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). These results are consistent with these predictions, in that the C-terminal portion of TXNIP is sufficient to bind and clear GLUT1 from cell surface, while the N-domain is not.</p><p>Cone survival was assayed in vivo following infection of <italic>rd1</italic> with these missense and deletion alleles at P0 and sacrifice at P50 (<xref ref-type="fig" rid="fig2">Figure 2B–G</xref>). Similar to Best1-wt Txnip (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>), Best1-Txnip.C247S did not show significant improvement of cone survival, ruling out the C247S mutation alone as promoting the cone survival by Best1-Txnip.C247S.LL351 and 352AA. In addition, Best1-N.Txnip (1-228aa) and Best1-sC.Txnip (255-397aa, sC: short C-) failed to improve cone survival. However, Best1-C.Txnip.C247S (149-397aa), Best1-C.Txnip.C247S.LL351 and 352AA (149-397aa), and Best1-nt.Txnip.C247S<sup>320</sup> (1-320aa, nt: no-tail) promoted significant cone survival compared to the corresponding control retinas. Best1-N.Txnip and Best1-sC.Txnip-treated <italic>rd1</italic> retina did not have increased numbers of craters, while all other vectors increased the number of craters. These results suggest that the C-terminal portion of TXNIP expressed in the RPE is required for RP cone survival, for a function(s) that is unrelated to the removal of GLUT1, or to the mechanism that leads to an increase in craters.</p></sec><sec id="s2-3"><title>Evaluation of <italic>Txnip</italic> deletion alleles for autonomous cone survival</title><p>Our previous study used the human red opsin promoter, ‘RedO,’ in AAV to drive the expression of Txnip in <italic>rd1</italic> cones, with a low level of expression in some rods. This same strategy was used to evaluate whether the aforementioned deletion alleles of <italic>Txnip</italic> could prolong cone survival. Neither N.Txnip (1-228aa) nor C.Txnip.C247S (149-397aa) promoted significant improvement in <italic>rd1</italic> cone survival. However, nt.Tnxip.C247S<sup>301</sup> (1-301aa) and nt.Txnip.C247S<sup>320</sup> (1-320aa) promoted survival of <italic>rd1</italic> cones: 47% and 63% more cones than the control GFP virus, respectively (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). In comparison, the full-length Txnip.C247S promoted an increase of 97% in cones in our previous study (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). These results show that the full-length Txnip provides the most benefit in terms of RP cone survival. To determine if expression of this allele might give increased survival when expressed in both the RPE and in cones, we used a CMV promoter to drive expression, as CMV expresses highly in both cell types (<xref ref-type="bibr" rid="bib35">Xiong et al., 2015</xref>). CMV-Txnip.C247S provided a 38% rescue (<xref ref-type="fig" rid="fig3">Figure 3A and C</xref>), which is lower than RedO-Txnip.C247S (97%) alone. These and previous results are summarized in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Tests of <italic>Txnip</italic> alleles on cone survival.</title><p>(<bold>A</bold>) Representative P50 <italic>rd1</italic> flat-mounted retinas after P0 infection with 1 of 5 different <italic>Txnip</italic> alleles (AAV8-RedO- N.Txnip /C.Txnip.C247S/ nt.Txnip.C247S<sup>1-301</sup>/nt.Txnip.C247S<sup>1-320</sup> or AAV8-CMV-Txnip.C247S, ≈1×10<sup>9</sup> vg/eye, plus AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye), or control eyes infected with AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye alone. (<bold>B, C</bold>) Quantification of H2BGFP-positive cones within the center of P50 <italic>rd1</italic> retinas transduced with AAV8-RedO- N.Txnip /C.Txnip.C247S/ nt.Txnip.C247S<sup>1-301</sup>/nt.Txnip.C247S<sup>1-320</sup> or AAV8-CMV-Txnip.C247S, and control (same as in A). The number in the round brackets ‘()’ indicates the number of retinas within each group. Error bar: standard deviation. Statistics: ANOVA and Dunnett’s multiple comparison test for B; two-tailed unpaired Student’s t-test for C. NS: not significant, ****p&lt;or &lt;&lt; 0.0001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>This file contains the source data of <xref ref-type="fig" rid="fig3">Figure 3B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90749-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig3-v1.tif"/></fig><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Summary of various alleles of <italic>Txnip</italic> in this and previous study (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>).</title><p>‘Retinal pigmented epithelium (RPE) Glucose transporter 1 (GLUT1) Removal’ refers to the amount of GLUT1 immunohistochemical signal on the basal surface following expression in the RPE using the Best1 promoter. ‘Cone Rescue: Expression in RPE’ refers to cone rescue following expression only in the RPE using the Best1 promoter. ‘Cone Rescue: Expression in Cones’ is due to expression only in cone photoreceptors using the RedO promoter. Abbreviations: Y (x%): Yes with x% increase compared to AAV-H2BGFP control; N: No; NT: Not tested. N.TXNIP, N-terminal portion of TXNIP; C.TXNIP.C247S, C-terminal portion of TXNIP.C247S mutant allele; sC.TXNIP: a shorter version of C-terminal portion of TXNIP; nt.TXNIP.C247S, no tail version TXNIP.C247S mutant allele; Arrestin N-, N-terminal arrestin domain; Arrestin C-, C-terminal arrestin domain; PPxY, a motif where P is proline, x is any amino acid and Y is tyrosine.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig4-v1.tif"/></fig></sec><sec id="s2-4"><title>Inhibiting <italic>Hsp90ab1</italic> prolongs <italic>rd1</italic> cone survival</title><p>To further investigate the potential mechanism(s) of cone survival induced by Txnip, we considered the list of protein interactors that were identified in HEK293 cells using biotinylated protein interaction pull-down assay plus mass spectrometry (<xref ref-type="bibr" rid="bib5">Forred et al., 2016</xref>). Forred et al. identified a subset of proteins that interact with Txnip.C247S, the mutant that provides better cone rescue than the wt <italic>Txnip</italic> allele (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). As we found that Txnip promotes the use of lactate in cones, and improves mitochondrial morphology and function, we looked for TXNIP interactors that are relevant to mitochondria. We identified two candidates, PARP1 and HSP90AB1. PARP1 mutants have been shown to protect mitochondria under stress (<xref ref-type="bibr" rid="bib7">Hocsak et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Szczesny et al., 2014</xref>). Accordingly, in our previous study, we crossed the null PARP1 mice with <italic>rd1</italic> mice, to ask if mitochondrial improvements alone were sufficient to induce cone rescue. We found that it was not. In our current study, we thus prioritized HSP90AB1 inhibition, which had been shown to improve skeletal muscle mitochondrial metabolism in a diabetes mouse model (<xref ref-type="bibr" rid="bib13">Jing et al., 2018</xref>).</p><p>Three shRNAs targeting different regions of the mRNA of <italic>Hsp90ab1</italic> (shHsp90ab1) were delivered by AAV into the retinas of wt mice. Knock-down was evaluated using an AAV encoding a FLAG-tagged HSP90AB1 that was co-injected with the AAV-shRNA. All three shRNAs reduced the HSP90AB1-FLAG signal compared to the shNC, the non-targeting control shRNA (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>), suggesting that they are able to inhibit the expression of HSP90AB1 protein in vivo. The promotion of cone survival was then tested in <italic>rd1</italic> mice using these shRNA constructs. The two shRNAs with the most activity in reducing the FLAG-tagged HSP90AB1 signal, shHsp90ab1<sup>(#a)</sup>, and shHsp90ab1<sup>(#c)</sup>, were found to increase the survival of <italic>rd1</italic> cones at P50 (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). To determine if this effect was capable of increasing the Txnip rescue, the shRNAs were co-injected with Txnip.C247S. A slight additive effect of shHsp90ab1 and Txnip.C247S was observed (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). We also asked if there might be an effect of the knock-down of <italic>Hsp90ab1</italic> on a <italic>Parp1</italic> loss of function background. We did not observe any rescue effect of the shRNAs on this background (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Effect of knockdown of <italic>Hsp90ab1</italic> in retinitis pigmentosa cones in vivo.</title><p>(<bold>A</bold>) AAV8-RO1.7-Hsp90ab1-FLAG (1×10<sup>9</sup> vg/eye) co-injected with shNC (non-targeting shRNA control, AAV8-RedO-shRNA, 1×10<sup>9</sup> vg/eye) or co-injected with <italic>Hsp90ab1</italic> shRNAs #a, #b, #c (AAV8-RedO-shRNA, 1×10<sup>9</sup> vg/eye) in P20 wild-type (wt) retina, all also injected with AAV8-RedO-H2BGFP (2.5×10<sup>8</sup> vg/eye) to track the infection. Magenta: anti-FLAG; green: anti-GFP; gray: DAPI. Right panel: (<bold>B</bold>) The quantification of FLAG intensity from multiple fields of inner segment regions in A. The number in the square brackets ‘[]’ indicates the number of images taken from regions of interest of one retina, in each condition. (<bold>C</bold>) Representative P50 <italic>rd1</italic> flat-mounted retinas injected with shNC, shHsp90ab1(#a), shHsp90ab1(#b), or shHsp90ab1(#c) (AAV8-RedO-shRNAs, 1×10<sup>9</sup> vg/eye, plus AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye). (<bold>D</bold>) Quantification of H2BGFP-positive cones within the center of P50 <italic>rd1</italic> retinas transduced with shNC, shHsp90ab1(#a, #b, #c) (same as in C). (<bold>E</bold>) Representative P50 <italic>rd1</italic> flat-mounted retinas with H2BGFP (gray)-labeled cones transduced with Txnip.C247S or Txnip.C247S+shHsp90ab1 (AAV8-RedO-Txnip.C247S, 1×10<sup>9</sup> vg/eye; AAV8-RO1.7-shHsp90ab1(#a or #c), 1×10<sup>9</sup> vg/eye; plus AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye). (<bold>F</bold>) Quantification of H2BGFP-positive cones within the center of P50 <italic>rd1</italic> retinas transduced with Txnip.C247S or Txnip.C247S+shHsp90ab1 (same as in E). (<bold>G</bold>) Representative P50 <italic>Parp1</italic><sup>-/-</sup> <italic>rd1</italic> flat-mounted retinas with H2BGFP (gray)-labeled cones transduced with shNC (non-targeting shRNA control, AAV8-RedO-shRNA, 1×10<sup>9</sup> vg/eye; plus AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye) or shHsp90ab1 (AAV8-RedO-shRNA #a or #c, 1×10<sup>9</sup> vg/eye; plus AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye). (<bold>H</bold>) Quantification of H2BGFP-positive cones within the center of P50 <italic>Parp1</italic><sup>-/-</sup> <italic>rd1</italic> retinas transduced with shNC or shHsp90ab1 (same as in G). Error bar: standard deviation. Statistics: ANOVA and Dunnett’s multiple comparison test for B and D; two-tailed unpaired Student’s t-test for F and H. NS: not significant, p&gt;0.05, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 ****p&lt;or &lt;&lt; 0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>This file contains the source data of <xref ref-type="fig" rid="fig5">Figure 5B, D, F and H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90749-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Predicted 3D protein structures of HSP90AB1 and PARP1.</title><p>(<bold>A</bold>) Predicted 3D protein structures of HSP90AB1 by AI algorithm AlphaFold-2 from two angles of view. (<bold>B</bold>) Predicted 3D protein structures of PARP1 by AI algorithm AlphaFold-2 from two angles of view.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Predicted 3D protein interactions among TXNIP, HSP90AB1, and PARP1 by AI algorithm AlphaFold Multimer from two angles of view.</title><p>Abbreviations: Arr C-, C-terminal arrestin domain.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90749-fig5-figsupp2-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In RP, the RPE cells and cones degenerate due to non-autonomous causes after the death of rods. Although the causes of cone death are not entirely clear, one model proposes that they do not have enough glucose, their main fuel source (<xref ref-type="bibr" rid="bib8">Hurley, 2021</xref>; <xref ref-type="bibr" rid="bib27">Punzo et al., 2009</xref>; <xref ref-type="bibr" rid="bib37">Xue and Cepko, 2023</xref>). In a previous study, we found that Txnip promoted the use of lactate within cones and led to healthier mitochondria. The mechanisms for these effects are unclear, and we sought to determine what domains of TXNIP might contribute to these effects, as well as explore alleles of <italic>Txnip</italic> that might be more potent for cone survival. We further tested the rescue effects of several alleles when expressed in the RPE, a support layer for cones, through which nutrients, such as glucose, flow to the cones from the choriocapillaris. The results suggest that Txnip has different mechanisms for Txnip-mediated cone survival when expressed in the RPE versus in cones.</p><p>The C-terminal portion of Txnip.C247S (149-397aa) expressed within the RPE, but not within cones, delayed the degeneration of cones (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The full-length Txnip.C247S expressed within cones, but not within the RPE, was the most effective configuration for cone survival (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The expression of full-length Txnip.C247S in both the RPE and cones did not provide better rescue than in cones alone. As TXNIP has several domains that presumably interact with different partners, it is possible that these different effects on cone survival are due to the interaction of different TXNIP domains with different partners in the RPE versus the cones, or different results from the interactions of the same domains and partners in the two cell types. The N-terminal half of TXNIP (1-228aa) might exert harmful effects in the RPE, that negate the beneficial effects from the C-terminal half, suggested by the observation that its removal, in the C-terminal 149–397 allele, led to better cone survival when expressed in the RPE (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In cones, the C-terminal half, including the C-terminal IDR tail, may cooperate with the N-terminal half, or negate its negative effects, to benefit RP cone survival. However, the C-terminal half is not sufficient for cone rescue when expressed in cones, as the 149–397 allele did not rescue.</p><p>The C-terminal half of TXNIP apparently affects cone survival differently when expressed within the two cell types. This notion is informed by the different rescue effects of expression of the 149–397 allele, which rescues cones when expressed in the RPE, but not when expressed in cones. This domain loses the cone rescue activity if it loses aa 149–254, when expressed in the RPE, as shown by the 255–397 allele. In cones, the rescue activity is present in the 1–301 and the 1–320 allele, but is lost in the 149–397 allele. It is possible that effects on protein structure cause this loss, or that an interaction between N-terminal and C-terminal domains is required for cone rescue within cones.</p><p>One TXNIP function that likely is important to these effects in the two cell types is TXNIP’s removal of the glucose transporter from the plasma membrane. The LLAA TXNIP mutant is unable to effectively remove the transporter, due to its loss of interaction with clathrin (<xref ref-type="bibr" rid="bib33">Wu et al., 2013</xref>). When this mutant allele is expressed in the RPE, it leads to improved cone survival, in contrast to the wt allele. This might be due to better health in the RPE, when it is able to take up glucose to fuel its own metabolism, and/or to provide glucose to cones. When the LLAA allele is expressed in cones, it also promotes cone survival, though not as well as the wt allele (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). The wt allele might be more beneficial in cones if it is part of the mechanism that forces cones to rely more heavily on lactate vs. glucose. All of these observations of cone rescue from expression within cones suggest that cone rescue relies on activities that reside in both the N and C-terminal portions, including the ability of TXNIP to interact with clathrin. However, it will be important to probe structural alterations and stability of TXNIP in cones and RPE when these various alleles are expressed to further support these hypotheses.</p><p>ARRDC4, the most similar α-arrestin protein to TXNIP that also has Arrestin N- and C- domains, accelerated RP cone death when transduced via AAV (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This observation suggests that TXNIP has unique functions that protect RP cones. Recently, ARRDC4 has been proposed to be critical for liver glucagon signaling, which could be negated by insulin (<xref ref-type="bibr" rid="bib2">Dagdeviren et al., 2023</xref>). The implication of this potential role regarding RP cone survival is unclear, but interestingly, the activation of the insulin/mTORC1 pathway is beneficial to RP cone survival (<xref ref-type="bibr" rid="bib27">Punzo et al., 2009</xref>; <xref ref-type="bibr" rid="bib30">Venkatesh et al., 2015</xref>).</p><p>Regarding potential protein interactions beyond the glucose transporter, the interaction of TXNIP with thioredoxin is apparently negative for cone survival, as we found in our previous study with the C247S allele. This is most easily understood by the release of thioredoxin from TXNIP, whereupon it can play its anti-oxidation role, which would be important in the RP retina which exhibits oxidative damage. It also would free TXNIP to interact with other partners, of which there are several, though many also depend upon C247 (<xref ref-type="bibr" rid="bib5">Forred et al., 2016</xref>). Another partner interaction suggested by previous studies and explored here is the interaction with HSP90AB1 (<xref ref-type="fig" rid="fig5">Figure 5</xref>). HSP90AB1 interacts with both the wt and C247S alleles (<xref ref-type="bibr" rid="bib5">Forred et al., 2016</xref>). Little is known about the function of HSP90AB1. Knocking down <italic>Hsp90ab1</italic> improved mitochondrial metabolism of skeletal muscle in a diabetic mouse model (<xref ref-type="bibr" rid="bib13">Jing et al., 2018</xref>). Knocking out HSP90AA1, a paralog of HSP90AB1 which has 14% different amino acids, led to rod death and correlated with PDE6 dysregulation (<xref ref-type="bibr" rid="bib19">Munezero et al., 2023</xref>). Inhibiting HSP90AA1 with small molecules transiently delayed cone death in human retinal organoids under low glucose conditions (<xref ref-type="bibr" rid="bib28">Spirig et al., 2023</xref>). However, the exact role of HSP90AA1 in photoreceptors needs to be clarified, and the implications for HSP90AB1 in RP cones are still unclear.</p><p>Here, we found that sh-mediated knock-down of <italic>Hsp90ab1</italic> enhanced cone survival in <italic>rd1</italic> mice. This rescue seems to be dependent on PARP1, another binding partner of wt TXNIP and Txnip.C247S (<xref ref-type="bibr" rid="bib5">Forred et al., 2016</xref>). As shown by PARP1 knock-out mice, PARP1 is deleterious to mitochondrial heath under stressful conditions (<xref ref-type="bibr" rid="bib7">Hocsak et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Szczesny et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). When we examined a possible rescue effect of PARP1 loss on <italic>rd1</italic> cone survival, we did not see a benefit, indicating that the TXNIP-mediated rescue is not due solely to its beneficial effects on mitochondria, nor does TXNIP-mediated rescue rely upon PARP1 (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). These results indicate that the Txnip rescue is more complex than inhibition of HSP90AB1, and a PARP1-independent mechanism is involved. It is possible that HSP90AB1 directly interacts with PARP1, and this interaction is critical for shHsp90ab1 to benefit RP cones. We looked into the predicted 3D structures of HSP90AB1 and PARP1 using AlphaFold-2 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), but did not gain additional insight into such interactions. We also explored AlphaFold Multimer, which is an algorithm predicting the interaction of multiple proteins based upon AlphaFold-2 (<xref ref-type="bibr" rid="bib4">Evans et al., 2021</xref>), and noticed that the Arrestin-C domain of TXNIP linked PARP1 and HSP90AB1 together in one of the predicted models (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Despite the unclear mechanism, combining <italic>Hsp90ab1</italic> inhibition with Txnip.C247S could be a potential combination therapy to maximize the protection of RP cones.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">GLUT1 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab115730</td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Arrdc4</italic> cDNA</td><td align="left" valign="bottom">GeneCopoeia</td><td align="left" valign="bottom">Cat. #: Mm26972 NCBI: NM_001042592.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Hsp90ab1</italic> cDNA</td><td align="left" valign="bottom">GeneCopoeia</td><td align="left" valign="bottom">Cat. #: Mm03161 NCBI: NM_008302.3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Protein 3D structure prediction</td><td align="left" valign="bottom">AlphaFold-2</td><td align="left" valign="bottom">TXNIP (<italic>M. musculus</italic>); ARRDC4 (<italic>M. musculus</italic>); HSP90AB1 (<italic>M. musculus</italic>); PARP1 (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Jumper et al., 2021</xref>;<break/><ext-link ext-link-type="uri" xlink:href="https://alphafold.ebi.ac.uk">https://alphafold.ebi.ac.uk</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Protein 3D interaction prediction</td><td align="left" valign="bottom">ColabFold</td><td align="left" valign="bottom">AlphaFold2_mmseqs2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Mirdita et al., 2022</xref>;<break/><xref ref-type="bibr" rid="bib23">Ovchinnikov, 2021</xref>;<break/><ext-link ext-link-type="uri" xlink:href="https://github.com/sokrypton/colabfold">https://github.com/sokrypton/colabfold</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Protein 3D interaction prediction</td><td align="left" valign="bottom">COSMIC2</td><td align="left" valign="bottom">AlphaFold2 – Multimer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Evans et al., 2021</xref>;<break/><ext-link ext-link-type="uri" xlink:href="http://cosmic-cryoem.org/tools/alphafoldmultimer/">http://cosmic-cryoem.org/tools/alphafoldmultimer/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Protein 3D structure viewer</td><td align="left" valign="bottom">RCSB PDB</td><td align="left" valign="bottom">Mol* 3D Viewer</td><td align="left" valign="bottom">To visualize the 3D structure of proteins in.pdb files <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/3d-view">https://www.rcsb.org/3d-view</ext-link></td></tr></tbody></table></table-wrap><p>The material and methods in this study are similar to those used in our previous study (<xref ref-type="bibr" rid="bib36">Xue et al., 2021</xref>). The cone number of the central retina is defined as the counts of H2BGFP-positive cells within the central portion of the retina. New reagents and algorithms used in this study are listed in the Key resources table above. <italic>Txnip</italic> deletion alleles were cloned from the Txnip plasmid using Gibson assembly (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The following sense strand sequences were used to knock down the <italic>Hsp90ab1</italic>: shHsp90ab1(#a) 5′- <named-content content-type="sequence">GCATCTACCGCATGATTAAAC</named-content>-3′; shHsp90ab1(#b) 5′- <named-content content-type="sequence">CCAGAAGTCCATCTACTATAT</named-content>-3′; shHsp90ab1(#c) 5′- <named-content content-type="sequence">CCTGAGTACCTCAACTTTATC</named-content>-3′. In almost all experiments, other than as noted, one eye of the mouse was treated with control (AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye), and the other eye was treated with the experimental vector plus AAV8-RedO-H2BGFP, 2.5×10<sup>8</sup> vg/eye. For RPE basal surface GLUT1 quantification, multiple regions of interest (ROI) were selected from at least three eyes of each condition, and the mean intensity of the ROI was measured using ImageJ software. Statistics are listed in each figure legend.</p></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the Harvard Medical Area (#IS00001695-3) and Lingang Laboratory (#NZXSP-2022-4). The protocol was approved by the Harvard Medical Area Standing Committee on Animals (assurance number: D16-00270) or IACUC committee of Lingang Laboratory.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-90749-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated during this study are included in the manuscript and supporting files; source data files have been provided for all figures.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank John Dingus, Sophia Zhao, and Paula Montero-Llopis (Microscopy Resources on the North Quad) of Harvard Medical School, Xiaomei Sun and Peimin Ma of Lingang Laboratory, Li Tan and Kangning Sang (Optical Imaging Core Facility) of Shanghai Research Center for Brain Science and Brain-Inspired Intelligence for advisory and technical support. This work was funded by Howard Hughes Medical Institute (to CLC), National Institutes of Health (NIH) grants K99EY030951 (to YX before June 30, 2022), Lingang Laboratory startup fund (to YX after July 20, 2022).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chrenek</surname><given-names>MA</given-names></name><name><surname>Dalal</surname><given-names>N</given-names></name><name><surname>Gardner</surname><given-names>C</given-names></name><name><surname>Grossniklaus</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Boatright</surname><given-names>JH</given-names></name><name><surname>Nickerson</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Analysis of the RPE sheet in the rd10 retinal degeneration model</article-title><source>Advances in Experimental Medicine and Biology</source><volume>723</volume><fpage>641</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1007/978-1-4614-0631-0_81</pub-id><pub-id pub-id-type="pmid">22183388</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagdeviren</surname><given-names>S</given-names></name><name><surname>Hoang</surname><given-names>MF</given-names></name><name><surname>Sarikhani</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>V</given-names></name><name><surname>Benoit</surname><given-names>JC</given-names></name><name><surname>Okawa</surname><given-names>MC</given-names></name><name><surname>Melnik</surname><given-names>VY</given-names></name><name><surname>Ricci-Blair</surname><given-names>EM</given-names></name><name><surname>Foot</surname><given-names>N</given-names></name><name><surname>Friedline</surname><given-names>RH</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Tauer</surname><given-names>LA</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Prigozhin</surname><given-names>MB</given-names></name><name><surname>Shenoy</surname><given-names>SK</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>An insulin-regulated arrestin domain protein controls hepatic glucagon action</article-title><source>The Journal of Biological Chemistry</source><volume>299</volume><elocation-id>105045</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2023.105045</pub-id><pub-id pub-id-type="pmid">37451484</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esumi</surname><given-names>N</given-names></name><name><surname>Kachi</surname><given-names>S</given-names></name><name><surname>Hackler</surname><given-names>L</given-names></name><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>BEST1 expression in the retinal pigment epithelium is modulated by OTX family members</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>128</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn323</pub-id><pub-id pub-id-type="pmid">18849347</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>O’Neill</surname><given-names>M</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Antropova</surname><given-names>N</given-names></name><name><surname>Senior</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Blackwell</surname><given-names>S</given-names></name><name><surname>Yim</surname><given-names>J</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Protein complex prediction with alphafold-multimer</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.10.04.463034</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forred</surname><given-names>BJ</given-names></name><name><surname>Neuharth</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>DI</given-names></name><name><surname>Amolins</surname><given-names>MW</given-names></name><name><surname>Motamedchaboki</surname><given-names>K</given-names></name><name><surname>Roux</surname><given-names>KJ</given-names></name><name><surname>Vitiello</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification of redox and glucose-dependent Txnip Protein Interactions</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2016</volume><elocation-id>5829063</elocation-id><pub-id pub-id-type="doi">10.1155/2016/5829063</pub-id><pub-id pub-id-type="pmid">27437069</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartong</surname><given-names>DT</given-names></name><name><surname>Berson</surname><given-names>EL</given-names></name><name><surname>Dryja</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Retinitis pigmentosa</article-title><source>Lancet</source><volume>368</volume><fpage>1795</fpage><lpage>1809</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)69740-7</pub-id><pub-id pub-id-type="pmid">17113430</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hocsak</surname><given-names>E</given-names></name><name><surname>Szabo</surname><given-names>V</given-names></name><name><surname>Kalman</surname><given-names>N</given-names></name><name><surname>Antus</surname><given-names>C</given-names></name><name><surname>Cseh</surname><given-names>A</given-names></name><name><surname>Sumegi</surname><given-names>K</given-names></name><name><surname>Eros</surname><given-names>K</given-names></name><name><surname>Hegedus</surname><given-names>Z</given-names></name><name><surname>Gallyas</surname><given-names>F</given-names></name><name><surname>Sumegi</surname><given-names>B</given-names></name><name><surname>Racz</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway</article-title><source>Free Radical Biology &amp; Medicine</source><volume>108</volume><fpage>770</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.04.018</pub-id><pub-id pub-id-type="pmid">28457938</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Retina metabolism and metabolism in the pigmented epithelium: a busy intersection</article-title><source>Annual Review of Vision Science</source><volume>7</volume><fpage>665</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1146/annurev-vision-100419-115156</pub-id><pub-id pub-id-type="pmid">34102066</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>J</given-names></name><name><surname>Suh</surname><given-names>H-W</given-names></name><name><surname>Jeon</surname><given-names>YH</given-names></name><name><surname>Hwang</surname><given-names>E</given-names></name><name><surname>Nguyen</surname><given-names>LT</given-names></name><name><surname>Yeom</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S-G</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>KJ</given-names></name><name><surname>Kang</surname><given-names>BS</given-names></name><name><surname>Jeong</surname><given-names>J-O</given-names></name><name><surname>Oh</surname><given-names>T-K</given-names></name><name><surname>Choi</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>J-O</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>2958</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms3958</pub-id><pub-id pub-id-type="pmid">24389582</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KN</given-names></name><name><surname>Hwang</surname><given-names>CY</given-names></name><name><surname>Kwon</surname><given-names>KS</given-names></name><name><surname>You</surname><given-names>KH</given-names></name><name><surname>Choi</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1</article-title><source>Cancer Research</source><volume>65</volume><fpage>4485</fpage><lpage>4489</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2271</pub-id><pub-id pub-id-type="pmid">15930262</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>CL</given-names></name><name><surname>Grzywacz</surname><given-names>NM</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rearrangement of the cone mosaic in the retina of the rat model of retinitis pigmentosa</article-title><source>The Journal of Comparative Neurology</source><volume>520</volume><fpage>874</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1002/cne.22800</pub-id><pub-id pub-id-type="pmid">22102145</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>WQ</given-names></name><name><surname>Eom</surname><given-names>YS</given-names></name><name><surname>Bruce</surname><given-names>F</given-names></name><name><surname>Craft</surname><given-names>CM</given-names></name><name><surname>Grzywacz</surname><given-names>NM</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The effect of TIMP-1 on the cone mosaic in the retina of the rat model of retinitis pigmentosa</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>56</volume><fpage>352</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1167/iovs.14-15398</pub-id><pub-id pub-id-type="pmid">25515575</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>E</given-names></name><name><surname>Sundararajan</surname><given-names>P</given-names></name><name><surname>Majumdar</surname><given-names>ID</given-names></name><name><surname>Hazarika</surname><given-names>S</given-names></name><name><surname>Fowler</surname><given-names>S</given-names></name><name><surname>Szeto</surname><given-names>A</given-names></name><name><surname>Gesta</surname><given-names>S</given-names></name><name><surname>Mendez</surname><given-names>AJ</given-names></name><name><surname>Vishnudas</surname><given-names>VK</given-names></name><name><surname>Sarangarajan</surname><given-names>R</given-names></name><name><surname>Narain</surname><given-names>NR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hsp90β knockdown in DIO mice reverses insulin resistance and improves glucose tolerance</article-title><source>Nutrition &amp; Metabolism</source><volume>15</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1186/s12986-018-0242-6</pub-id><pub-id pub-id-type="pmid">29434648</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komeima</surname><given-names>K</given-names></name><name><surname>Rogers</surname><given-names>BS</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Antioxidants reduce cone cell death in a model of retinitis pigmentosa</article-title><source>PNAS</source><volume>103</volume><fpage>11300</fpage><lpage>11305</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604056103</pub-id><pub-id pub-id-type="pmid">16849425</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krol</surname><given-names>J</given-names></name><name><surname>Busskamp</surname><given-names>V</given-names></name><name><surname>Markiewicz</surname><given-names>I</given-names></name><name><surname>Stadler</surname><given-names>MB</given-names></name><name><surname>Ribi</surname><given-names>S</given-names></name><name><surname>Richter</surname><given-names>J</given-names></name><name><surname>Duebel</surname><given-names>J</given-names></name><name><surname>Bicker</surname><given-names>S</given-names></name><name><surname>Fehling</surname><given-names>HJ</given-names></name><name><surname>Schübeler</surname><given-names>D</given-names></name><name><surname>Oertner</surname><given-names>TG</given-names></name><name><surname>Schratt</surname><given-names>G</given-names></name><name><surname>Bibel</surname><given-names>M</given-names></name><name><surname>Roska</surname><given-names>B</given-names></name><name><surname>Filipowicz</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs</article-title><source>Cell</source><volume>141</volume><fpage>618</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.03.039</pub-id><pub-id pub-id-type="pmid">20478254</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Schütze</surname><given-names>K</given-names></name><name><surname>Moriwaki</surname><given-names>Y</given-names></name><name><surname>Heo</surname><given-names>L</given-names></name><name><surname>Ovchinnikov</surname><given-names>S</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>ColabFold: making protein folding accessible to all</article-title><source>Nature Methods</source><volume>19</volume><fpage>679</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01488-1</pub-id><pub-id pub-id-type="pmid">35637307</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohand-Said</surname><given-names>S</given-names></name><name><surname>Deudon-Combe</surname><given-names>A</given-names></name><name><surname>Hicks</surname><given-names>D</given-names></name><name><surname>Simonutti</surname><given-names>M</given-names></name><name><surname>Forster</surname><given-names>V</given-names></name><name><surname>Fintz</surname><given-names>AC</given-names></name><name><surname>Léveillard</surname><given-names>T</given-names></name><name><surname>Dreyfus</surname><given-names>H</given-names></name><name><surname>Sahel</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse</article-title><source>PNAS</source><volume>95</volume><fpage>8357</fpage><lpage>8362</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.14.8357</pub-id><pub-id pub-id-type="pmid">9653191</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munezero</surname><given-names>D</given-names></name><name><surname>Aliff</surname><given-names>H</given-names></name><name><surname>Salido</surname><given-names>E</given-names></name><name><surname>Saravanan</surname><given-names>T</given-names></name><name><surname>Sanzhaeva</surname><given-names>U</given-names></name><name><surname>Guan</surname><given-names>T</given-names></name><name><surname>Ramamurthy</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>HSP90α is needed for the survival of rod photoreceptors and regulates the expression of rod PDE6 subunits</article-title><source>The Journal of Biological Chemistry</source><volume>299</volume><elocation-id>104809</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2023.104809</pub-id><pub-id pub-id-type="pmid">37172722</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napoli</surname><given-names>D</given-names></name><name><surname>Biagioni</surname><given-names>M</given-names></name><name><surname>Billeri</surname><given-names>F</given-names></name><name><surname>Di Marco</surname><given-names>B</given-names></name><name><surname>Orsini</surname><given-names>N</given-names></name><name><surname>Novelli</surname><given-names>E</given-names></name><name><surname>Strettoi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Retinal pigment epithelium remodeling in mouse models of retinitis pigmentosa</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>5381</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22105381</pub-id><pub-id pub-id-type="pmid">34065385</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napoli</surname><given-names>D</given-names></name><name><surname>Strettoi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Structural abnormalities of retinal pigment epithelial cells in a light-inducible, rhodopsin mutant mouse</article-title><source>Journal of Anatomy</source><volume>243</volume><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1111/joa.13667</pub-id><pub-id pub-id-type="pmid">35428980</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishinaka</surname><given-names>Y</given-names></name><name><surname>Masutani</surname><given-names>H</given-names></name><name><surname>Oka</surname><given-names>SI</given-names></name><name><surname>Matsuo</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Nishio</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>Y</given-names></name><name><surname>Yodoi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>37559</fpage><lpage>37565</lpage><pub-id pub-id-type="doi">10.1074/jbc.M405473200</pub-id><pub-id pub-id-type="pmid">15234975</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Ovchinnikov</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Colabfold</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/sokrypton/colabfold">https://github.com/sokrypton/colabfold</ext-link></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patwari</surname><given-names>P</given-names></name><name><surname>Higgins</surname><given-names>LJ</given-names></name><name><surname>Chutkow</surname><given-names>WA</given-names></name><name><surname>Yoshioka</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The interaction of thioredoxin with Txnip: evidence for formation of a mixed disulfide by disulfide exchange</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>21884</fpage><lpage>21891</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600427200</pub-id><pub-id pub-id-type="pmid">16766796</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patwari</surname><given-names>P</given-names></name><name><surname>Chutkow</surname><given-names>WA</given-names></name><name><surname>Cummings</surname><given-names>K</given-names></name><name><surname>Verstraeten</surname><given-names>V</given-names></name><name><surname>Lammerding</surname><given-names>J</given-names></name><name><surname>Schreiter</surname><given-names>ER</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>24996</fpage><lpage>25003</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.018093</pub-id><pub-id pub-id-type="pmid">19605364</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puca</surname><given-names>L</given-names></name><name><surname>Brou</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Α-arrestins - new players in Notch and GPCR signaling pathways in mammals</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>1359</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1242/jcs.142539</pub-id><pub-id pub-id-type="pmid">24687185</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punzo</surname><given-names>C</given-names></name><name><surname>Kornacker</surname><given-names>K</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1038/nn.2234</pub-id><pub-id pub-id-type="pmid">19060896</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Spirig</surname><given-names>SE</given-names></name><name><surname>Arteaga-Moreta</surname><given-names>VJ</given-names></name><name><surname>Raics</surname><given-names>Z</given-names></name><name><surname>Posada-Céspedes</surname><given-names>S</given-names></name><name><surname>Chreng</surname><given-names>S</given-names></name><name><surname>Galuba</surname><given-names>O</given-names></name><name><surname>Galuba</surname><given-names>I</given-names></name><name><surname>Claerr</surname><given-names>I</given-names></name><name><surname>Renner</surname><given-names>S</given-names></name><name><surname>Kleindienst</surname><given-names>PT</given-names></name><name><surname>Volak</surname><given-names>A</given-names></name><name><surname>Imbach</surname><given-names>J</given-names></name><name><surname>Malysheva</surname><given-names>S</given-names></name><name><surname>Siwicki</surname><given-names>RA</given-names></name><name><surname>Hahaut</surname><given-names>V</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Picelli</surname><given-names>S</given-names></name><name><surname>Cattaneo</surname><given-names>M</given-names></name><name><surname>Jüttner</surname><given-names>J</given-names></name><name><surname>Cowan</surname><given-names>CS</given-names></name><name><surname>Duckely</surname><given-names>M</given-names></name><name><surname>Baeschlin</surname><given-names>DK</given-names></name><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>Unterreiner</surname><given-names>V</given-names></name><name><surname>Roska</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cell Type-Focused Compound Screen in Human Organoids Reveals Molecules and Pathways Controlling Cone Photoreceptor Death</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.10.09.561525</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczesny</surname><given-names>B</given-names></name><name><surname>Brunyanszki</surname><given-names>A</given-names></name><name><surname>Olah</surname><given-names>G</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Szabo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>13161</fpage><lpage>13173</lpage><pub-id pub-id-type="doi">10.1093/nar/gku1089</pub-id><pub-id pub-id-type="pmid">25378300</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatesh</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Le</surname><given-names>YZ</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name><name><surname>Rüegg</surname><given-names>MA</given-names></name><name><surname>Punzo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Activated mTORC1 promotes long-term cone survival in retinitis pigmentosa mice</article-title><source>The Journal of Clinical Investigation</source><volume>125</volume><fpage>1446</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.1172/JCI79766</pub-id><pub-id pub-id-type="pmid">25798619</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Macke</surname><given-names>JP</given-names></name><name><surname>Merbs</surname><given-names>SL</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name><name><surname>Klaunberg</surname><given-names>B</given-names></name><name><surname>Bennett</surname><given-names>J</given-names></name><name><surname>Gearhart</surname><given-names>J</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>A locus control region adjacent to the human red and green visual pigment genes</article-title><source>Neuron</source><volume>9</volume><fpage>429</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(92)90181-c</pub-id><pub-id pub-id-type="pmid">1524826</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SK</given-names></name><name><surname>Lapan</surname><given-names>SW</given-names></name><name><surname>Hong</surname><given-names>CM</given-names></name><name><surname>Krause</surname><given-names>TB</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>In Situ</italic> detection of adeno-associated viral vector genomes with SABER-FISH</article-title><source>Molecular Therapy. Methods &amp; Clinical Development</source><volume>19</volume><fpage>376</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.omtm.2020.10.003</pub-id><pub-id pub-id-type="pmid">33209963</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Shaywitz</surname><given-names>A</given-names></name><name><surname>Dagon</surname><given-names>Y</given-names></name><name><surname>Tower</surname><given-names>C</given-names></name><name><surname>Bellinger</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>CH</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Asara</surname><given-names>J</given-names></name><name><surname>McGraw</surname><given-names>TE</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1</article-title><source>Molecular Cell</source><volume>49</volume><fpage>1167</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.01.035</pub-id><pub-id pub-id-type="pmid">23453806</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>DM</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name><name><surname>Ivanchenko</surname><given-names>MV</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name><name><surname>Piper</surname><given-names>M</given-names></name><name><surname>Rana</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>SK</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>West</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>SR</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Cicconet</surname><given-names>M</given-names></name><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa</article-title><source>JCI Insight</source><volume>6</volume><elocation-id>e145029</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.145029</pub-id><pub-id pub-id-type="pmid">33491671</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>MacColl Garfinkel</surname><given-names>AE</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Benowitz</surname><given-names>LI</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage</article-title><source>The Journal of Clinical Investigation</source><volume>125</volume><fpage>1433</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1172/JCI79735</pub-id><pub-id pub-id-type="pmid">25798616</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>SK</given-names></name><name><surname>Rana</surname><given-names>P</given-names></name><name><surname>West</surname><given-names>ER</given-names></name><name><surname>Hong</surname><given-names>CM</given-names></name><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>DM</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa</article-title><source>eLife</source><volume>10</volume><elocation-id>e66240</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.66240</pub-id><pub-id pub-id-type="pmid">33847261</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Gene therapies for retinitis pigmentosa that target glucose metabolism</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>01</volume><elocation-id>a041289</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a041289</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>SK</given-names></name><name><surname>Collin</surname><given-names>GB</given-names></name><name><surname>Kefalov</surname><given-names>VJ</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Chromophore supply modulates cone function and survival in retinitis pigmentosa mouse models</article-title><source>PNAS</source><volume>120</volume><elocation-id>e2217885120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2217885120</pub-id><pub-id pub-id-type="pmid">37252956</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>GJ</given-names></name><name><surname>Budzynski</surname><given-names>E</given-names></name><name><surname>Sonnentag</surname><given-names>P</given-names></name><name><surname>Nork</surname><given-names>TM</given-names></name><name><surname>Sheibani</surname><given-names>N</given-names></name><name><surname>Gurel</surname><given-names>Z</given-names></name><name><surname>Boye</surname><given-names>SL</given-names></name><name><surname>Peterson</surname><given-names>JJ</given-names></name><name><surname>Boye</surname><given-names>SE</given-names></name><name><surname>Hauswirth</surname><given-names>WW</given-names></name><name><surname>Chulay</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cone-specific promoters for gene therapy of achromatopsia and other retinal diseases</article-title><source>Human Gene Therapy</source><volume>27</volume><fpage>72</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1089/hum.2015.130</pub-id><pub-id pub-id-type="pmid">26603570</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Zabel</surname><given-names>MK</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Fariss</surname><given-names>RN</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Parkhurst</surname><given-names>CN</given-names></name><name><surname>Gan</surname><given-names>W-B</given-names></name><name><surname>Wong</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration</article-title><source>EMBO Molecular Medicine</source><volume>7</volume><fpage>1179</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.15252/emmm.201505298</pub-id><pub-id pub-id-type="pmid">26139610</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>CL</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Grzywacz</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Spatiotemporal pattern of rod degeneration in the S334ter-line-3 rat model of retinitis pigmentosa</article-title><source>Cell and Tissue Research</source><volume>351</volume><fpage>29</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s00441-012-1522-5</pub-id><pub-id pub-id-type="pmid">23143675</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90749.4.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eade</surname><given-names>Kevin</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Lowy Medical Research Institute</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>This <bold>fundamental</bold> study advances our understanding of the cell specific treatment of cone photoreceptor degeneration by Txnip. The evidence supporting the conclusions is <bold>compelling</bold> with rigorous genetic manipulation of Txnip mutations. The work will be of broad interest to vision researchers, cell biologists and biochemists.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90749.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This is a follow-up study to the authors' previous eLife report about the roles of an alpha-arrestin called protein thioredoxin interacting protein (Txnip) in cone photoreceptors and in the retinal pigment epithelium. The findings are important because they provide new information about the mechanism of glucose and lactate transport to cone photoreceptors and because they may become the basis for therapies for retinal degenerative diseases.</p><p>Strengths:</p><p>Overall, the study is carefully done and, although the analysis is fairly comprehensive with many different versions of the protein analyzed, it is clearly enough described to follow. Figure 4 greatly facilitated my ability to follow, understand and interpret the study. The authors have appropriately addressed a few concerns about statistical significance and the relationship between their findings and previous studies of the possible roles of Txnip on GLUT1 expression and localization on the surfaces of RPE cells.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90749.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The hard work of the authors is much appreciated. With overexpression of a-arrestin Txnip in RPE, cones and the combined respectively, the authors show a potential gene agnostic treatment that can be applied to retinitis pigmentosa. Furthermore, since Txnip is related to multiple intracellular signaling pathway, this study is of value for research in the mechanism of secondary cone dystrophy as well.</p><p>Strengths</p><p>- The follow-up study builds on innovative ground by exploring the impact of TxnipC247S and its combination with HSP90AB1 knockdown on cone survival, offering novel therapeutic pathways.</p><p>- Testing of different Txnip deletion mutants provides a nuanced understanding of its functional domains, contributing valuable insights into the mechanism of action in RP treatment.</p><p>- The findings regarding GLUT1 clearance and the differential effects of Txnip mutants on cone and RPE cells lay the groundwork for targeted gene therapy in RP.</p><p>Comments on revised version:</p><p>The researchers answered our questions and included additional discussion in the manuscript.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90749.4.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Yunlu</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yimin</given-names></name><role specific-use="author">Author</role><aff><institution>Lingang Laboratory</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Cepko</surname><given-names>Constance L</given-names></name><role specific-use="author">Author</role><aff><institution>Howard Hughes Medical Institute</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>This is a follow-up study to the authors' previous eLife report about the roles of an alpha-arrestin called protein thioredoxin interacting protein (Txnip) in cone photoreceptors and in the retinal pigment epithelium. The findings are important because they provide new information about the mechanism of glucose and lactate transport to cone photoreceptors and because they may become the basis for therapies for retinal degenerative diseases.</p><p>Strengths:</p><p>Overall, the study is carefully done and, although the analysis is fairly comprehensive with many different versions of the protein analyzed, it is clearly enough described to follow. Figure 4 greatly facilitated my ability to follow, understand and interpret the study. The authors have appropriately addressed a few concerns about statistical significance and the relationship between their findings and previous studies of the possible roles of Txnip on GLUT1 expression and localization on the surfaces of RPE cells.</p></disp-quote><p>We are delighted that Reviewer #1 is satisfied with this revised version.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>The hard work of the authors is much appreciated. With overexpression of a-arrestin Txnip in RPE, cones and the combined respectively, the authors show a potential gene agnostic treatment that can be applied to retinitis pigmentosa. Furthermore, since Txnip is related to multiple intracellular signaling pathway, this study is of value for research in the mechanism of secondary cone dystrophy as well.</p><p>There are a few areas in which the article may be improved through further analysis and application of the data, as well as some adjustments that should be made in to clarify specific points in the article.</p><p>Strengths</p><list list-type="bullet"><list-item><p>The follow-up study builds on innovative ground by exploring the impact of TxnipC247S and its combination with HSP90AB1 knockdown on cone survival, offering novel therapeutic pathways.</p></list-item></list><list list-type="bullet"><list-item><p>Testing of different Txnip deletion mutants provides a nuanced understanding of its functional domains, contributing valuable insights into the mechanism of action in RP treatment.</p></list-item></list><list list-type="bullet"><list-item><p>The findings regarding GLUT1 clearance and the differential effects of Txnip mutants on cone and RPE cells lay the groundwork for targeted gene therapy in RP.</p></list-item></list><p>Weaknesses</p><list list-type="bullet"><list-item><p>The focus on specific mutants and overexpression systems might overlook broader implications of Txnip interactions and its variants in the wider context of retinal degeneration.</p></list-item></list></disp-quote><p>Txnip is not expressed in WT or RP cones, as described in our previous study (Xue et al., 2021, eLife), so we could not perform loss of function assays. We thus chose overexpression, and assayed various alleles, based upon the literature, as we describe in our manuscript.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>The study's reliance on cell count and GLUT1 expression as primary outcomes misses an opportunity to include functional assessments of vision or retinal health, which would strengthen the clinical relevance.</p></list-item></list></disp-quote><p>In our previous study, we demonstrated that the optomotor response of Txnip-treated RP mice improved (Xue et al., 2021, eLife). Also, as described in our previous Txnip study, as well as an independent study (Xue et al., 2021, eLife; Xue et al., 2023, PNAS), ERG assays of Txnip-treated RP cones were no different than the controls. Other therapies that prolong RP cone survival and the optomotor response in our lab also failed to save the ERG, suggesting that there are other pathways that need to be addressed, e.g. the visual cycle. A combination therapy addressing multiple problems is one of our goals.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>The paper could benefit from a deeper exploration of why certain treatments (like Best1-146 Txnip.C247S) do not lead to cone rescue and the potential for these approaches to exacerbate disease phenotypes through glucose shortages.</p></list-item></list></disp-quote><p>This system is more complicated than we currently understand, and more work needs to be done.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>Minor inconsistencies, such as the missing space in text references and the need for clarification on data representation (retinas vs. mice), should be addressed for clarity and accuracy.</p></list-item></list></disp-quote><p>The missing spaces are added.</p><p>We described the strategy of injecting the same mouse in each eye, one eye with control and one with the experimental vector. However, the following sentence has been added to the Materials and Methods to better assist the reader:</p><p>“In almost all experiments, other than as noted, one eye of the mouse was treated with control (AAV8-RedO-H2BGFP, 2.5 × 108 vg/eye), and the other eye was treated with the experimental vector plus AAV8-RedO-H2BGFP, 2.5 × 108 vg/eye.”</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>The observation of promoter leakage and potential vector tropism issues raise questions about the specificity and efficiency of the gene delivery system, necessitating further discussion and validation.</p></list-item></list></disp-quote><p>The following sentences have been added to the Results. We do not think this phenomenon affects the practice of the experiments or the interpretation of the results in this study.</p><p>“To enable automated cone counting and trace the infection, we co-injected an AAV (AAV8-RedO-H2BGFP-WPRE-bGHpA) encoding an allele of GFP fused to histone 2B (H2BGFP), which localized to the nucleus. As the red opsin promoter was used to express this gene, H2BGFP was seen in cone nuclei, but not in the RPE, if AAV8-RedO-H2BGFP-WPRE-bGHpA was injected alone. However, when an AAV that expressed in the RPE, i.e. AAV8-Best1-Sv40intron-(Gene)-WPRE-bGHpA, was co-injected with AAV8-RedO-H2BGFP-WPRE-bGHpA, H2BGFP was expressed in the RPE, along with expression in cones (Figure 2A). We speculate that this is due to concatenation or recombination of the two genomes, such that the H2BGFP comes under the control of the RPE promoter. This may be due to the high copy number of AAV in the RPE, as it did not happen in the reverse combination, i.e. AAV with an RPE promoter driving GFP and a cone promoter driving another gene, perhaps due to the observation that the AAV genome copy number is »10 fold lower in cones than in the RPE (Wang et al., 2020).”</p></body></sub-article></article>